Literature DB >> 20420649

Liver transplantation in the United States, 1999-2008.

P J Thuluvath1, M K Guidinger, J J Fung, L B Johnson, S C Rayhill, S J Pelletier.   

Abstract

Changes in organ allocation policy in 2002 reduced the number of adult patients on the liver transplant waiting list, changed the characteristics of transplant recipients and increased the number of patients receiving simultaneous liver-kidney transplantation (SLK). The number of liver transplants peaked in 2006 and declined marginally in 2007 and 2008. During this period, there was an increase in donor age, the Donor Risk Index, the number of candidates receiving MELD exception scores and the number of recipients with hepatocellular carcinoma. In contrast, there was a decrease in retransplantation rates, and the number of patients receiving grafts from either a living donor or from donation after cardiac death. The proportion of patients with severe obesity, diabetes and renal insufficiency increased during this period. Despite increases in donor and recipient risk factors, there was a trend towards better 1-year graft and patient survival between 1998 and 2007. Of major concern, however, were considerable regional variations in waiting time and posttransplant survival. The current status of liver transplantation in the United States between 1999 and 2008 was analyzed using SRTR data. In addition to a general summary, we have included a more detailed analysis of liver transplantation for hepatitis C, retransplantation and SLK transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20420649     DOI: 10.1111/j.1600-6143.2010.03037.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  124 in total

1.  Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations.

Authors:  Ann Drobnik; Caroline Judd; David Banach; Joseph Egger; Kevin Konty; Eric Rude
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

2.  Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma.

Authors:  Jared A White; David T Redden; Mary Kate Bryant; David Dorn; Souheil Saddekni; Ahmed Kamel Abdel Aal; Jessica Zarzour; David Bolus; J Kevin Smith; Stephen Gray; Devin E Eckhoff; Derek A DuBay
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

3.  Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Authors:  Jennifer C Lai; Jacqueline G O'Leary; James F Trotter; Elizabeth C Verna; Robert S Brown; R Todd Stravitz; Jeffrey D Duman; Lisa M Forman; Norah A Terrault
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

Review 4.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

5.  Futility and rationing in liver retransplantation: when and how can we say no?

Authors:  Scott W Biggins
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

Review 6.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

7.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

8.  Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.

Authors:  Jagpreet Chhatwal; Shannon A Ferrante; Cliff Brass; Antoine C El Khoury; Margaret Burroughs; Bruce Bacon; Rafael Esteban-Mur; Elamin H Elbasha
Journal:  Value Health       Date:  2013 Sep-Oct       Impact factor: 5.725

9.  An examination of liver offers to candidates on the liver transplant wait-list.

Authors:  Jennifer Cindy Lai; Sandy Feng; John Paul Roberts
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

10.  Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors.

Authors:  Marcio F Chedid; Charles B Rosen; Scott L Nyberg; Julie K Heimbach
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.